用米诺环素减轻人类恐惧的记忆保留:一个随机的安慰剂对照试验
Yanfang Xia1,2, Jelena Wehrli3, Aslan Abivardi3,4
1Computational Psychiatry Research, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland. yanfang.xia@donders.ru.nl.
Translational psychiatry
|January 17, 2024
概括
米诺环素,一种MMP-9抑制剂,在人类中减弱了恐惧记忆的保留. 这表明米诺环素可以通过抑制恐惧记忆巩固来帮助预防焦虑和与压力相关的疾病.
科学领域:
- 神经科学是一个神经科学.
- 心理药理学 心理药理学
背景情况:
- 帕夫洛夫的恐惧调节模型是焦虑和压力障碍.
- 恐惧记忆的巩固涉及矩阵金属蛋白酶9 (MMP-9).
研究的目的:
- 调查米诺环素对恐惧记忆保留的影响.
- 评估米诺环林在预防与压力有关的疾病方面的潜力.
主要方法:
- 随机,双盲,安慰剂对照试验 (N=105) 的研究结果.
- 配置性恐惧条件化的范式.
- 在获取前服用米诺环素,在7天后进行保留测试.
- 测量了恐惧强化的惊 (初级) 和瞳孔膨胀 (二级).
主要成果:
- 米诺环素显著减弱了配置式恐惧记忆的保留.
- 米诺环素没有影响恐惧记忆的获取.
- 米诺环素没有影响声明性应急记忆.
结论:
- 提供了体外证据,证明米诺环素抑制了恐惧记忆的巩固.
- 表明米诺环林在PTSD的初级和二级预防中的潜力.
- 激励进一步研究米诺环林用于预防与压力相关的疾病.
相关概念视频
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K


